If any of your opponent's Active Pokémon are Evolved Pokémon, search your deck for any 1 card and put it into your hand. Shuffle your deck afterward.
Flip a coin. If heads, your opponent returns the Defending Pokémon and all cards attached to it to his or her hand. (If your opponent doesn't have any Benched Pokémon or other Active Pokémon, this attack does nothing.)
Ruby & Sapphire was released in 2003. Ruby & Sapphire is grouped under the EX era.
With 109 listed cards, this is a mid-size set by modern TCG standards. As of 2026, the set is 23 years old and fits a legacy-era profile.
Nosepass (#18) is one of the Rare prints in this expansion.
In 2003, Ruby & Sapphire introduced this print of Nosepass. Core profile: Its card type is Pokémon.
The rarity label is Rare. Printed HP is 60.
Energy typing is Fighting. Card subtype classification is Basic.
Notable move text references "Invisible Hand" and "Repulsion". The card has a weakness to Water.
For Nosepass in Ruby & Sapphire, the current reference price is $1.38. Its 7-day movement is largely flat at 0.0%.
It now sits 4.1% above its 30-day average of $1.33. In the past 90 days, observed prices ranged from $1.08 to $1.38 (22% spread), a moderate-volatility profile.
This version is categorized as Rare.
Other Nosepass printings create a useful comparison set for Nosepass. This comparison sample includes 6 alternatives across 6 sets.
In this sample, pricing ranges between $0.07 and $0.14 (100% total span). Relative to the alternative average ($0.10), this card is +1280%.
Notable alternatives include Nosepass #78 (Primal Clash) at $0.14, Nosepass #54 (Steam Siege) at $0.11, Nosepass #73 (Brilliant Stars) at $0.09, and Nosepass #96 (Rebel Clash) at $0.09.
Collector-focused market read: Weekly drift is minimal (0.0%), indicating a relatively balanced short-term market. Observed 90-day bounds of $1.08 and $1.38 create a 22% band, matching a moderate-volatility profile.
Versus the 30-day average ($1.33), the card is trading 4.1% higher. Graded context points to a substantial premium curve, with PSA 10 at +8610% above raw pricing.
PSA 10 is currently around $120.20.
